[go: up one dir, main page]

DK3397971T3 - Fremgangsmåde til bestemmelse af mængden af et HBA1C i en blodprøve - Google Patents

Fremgangsmåde til bestemmelse af mængden af et HBA1C i en blodprøve Download PDF

Info

Publication number
DK3397971T3
DK3397971T3 DK16826359.8T DK16826359T DK3397971T3 DK 3397971 T3 DK3397971 T3 DK 3397971T3 DK 16826359 T DK16826359 T DK 16826359T DK 3397971 T3 DK3397971 T3 DK 3397971T3
Authority
DK
Denmark
Prior art keywords
hba1c
determining
amount
blood sample
blood
Prior art date
Application number
DK16826359.8T
Other languages
English (en)
Inventor
Peter Warthoe
Original Assignee
W Health L P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by W Health L P filed Critical W Health L P
Application granted granted Critical
Publication of DK3397971T3 publication Critical patent/DK3397971T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721Haemoglobin
    • G01N33/723Glycosylated haemoglobin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6486Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK16826359.8T 2015-12-30 2016-12-29 Fremgangsmåde til bestemmelse af mængden af et HBA1C i en blodprøve DK3397971T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201500848 2015-12-30
PCT/EP2016/082830 WO2017114893A1 (en) 2015-12-30 2016-12-29 Method for determining the quantity of an hba1c in a blood sample

Publications (1)

Publication Number Publication Date
DK3397971T3 true DK3397971T3 (da) 2021-09-20

Family

ID=57799694

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16826359.8T DK3397971T3 (da) 2015-12-30 2016-12-29 Fremgangsmåde til bestemmelse af mængden af et HBA1C i en blodprøve

Country Status (6)

Country Link
US (1) US10948500B2 (da)
EP (1) EP3397971B1 (da)
JP (1) JP6960925B2 (da)
CN (1) CN109154623B (da)
DK (1) DK3397971T3 (da)
WO (1) WO2017114893A1 (da)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69108439T2 (de) 1990-05-01 1995-07-27 Nacalai Tesque Inc Verfahren zur Bestimmung des Glykationsprozentsatzes eines bestimmten Proteins.
GB9024771D0 (en) * 1990-11-14 1991-01-02 Axis Research Assay
CA2102417C (en) * 1992-03-04 2008-06-10 Douglas R. Brandt Determination of glycated hemoglobin by fluorescence quenching
DE4206932A1 (de) * 1992-03-05 1993-09-09 Boehringer Mannheim Gmbh Immunologische methode zur bestimmung eines haemoglobinderivates
GB9415143D0 (en) 1994-07-27 1994-09-14 Edwards Raymond Glycated haemoglobin assay
ES2210686T3 (es) 1997-07-24 2004-07-01 Saint-Gobain Glass France Parabrisas de vidrio estratificado destinado a ser utilizado simultaneamente como reflector para sistema hud.
DE19843094A1 (de) * 1998-09-21 2000-03-23 Roche Diagnostics Gmbh Verfahren zur Bestimmung von glykiertem Hämoglobin
US7235404B2 (en) * 2005-05-04 2007-06-26 Beckman Coulter, Inc. Cyanide-free lytic reagent composition and method of use for hemoglobin and white blood cell measurement
GB2436681B (en) * 2006-03-31 2010-10-13 Quotient Diagnostics Ltd Fluorescent assay
WO2010009459A1 (en) 2008-07-18 2010-01-21 Bayer Healthcare Llc Methods, devices, and systems for glycated hemoglobin analysis
EP2433140B1 (en) 2009-05-20 2015-02-11 Relia Diagnostic Systems, Inc. Systems and methods for determining the percentage of glycated hemoglobin
GB201305114D0 (en) * 2013-03-20 2013-05-01 Univ Bath Materials and methods for analysing glycation

Also Published As

Publication number Publication date
JP2019502123A (ja) 2019-01-24
CN109154623B (zh) 2022-04-05
CN109154623A (zh) 2019-01-04
JP6960925B2 (ja) 2021-11-05
US10948500B2 (en) 2021-03-16
EP3397971B1 (en) 2021-08-04
WO2017114893A1 (en) 2017-07-06
EP3397971A1 (en) 2018-11-07
US20190018024A1 (en) 2019-01-17

Similar Documents

Publication Publication Date Title
DK3138489T3 (da) Sæt til bestemmelse af en analytkoncentration
DK3548652T3 (da) Fremgangsmåder til proteinanalyse
DK3436998T3 (da) Instrument til overvågning af en analytkoncentration
DK3327141T3 (da) Fremgangsmåde til identificering af den cellulære sammensætning i en biologisk prøve
DK4349248T3 (da) Indretning til bestemmelse af beskadiget væv med subepidermal fugtmåling
DK3274885T3 (da) Fremgangsmåde til bestemmelse af mavetarmkanaldysbiose
DK3374748T3 (da) Fremgangsmåde til udarbejdelse af et prøveforsøg
DK3285784T3 (da) Fremgangsmåde til fremstilling af en prøve af fækal mikrobiota
DK3384274T3 (da) Fremgangsmåder til prøvekarakterisering
EP3349013A4 (en) AUTOMATED ANALYZER
PL3274469T3 (pl) Kompozycje i sposoby wykrywania zanieczyszczenia biologicznego
DK3314010T3 (da) Fremgangsmåde til detektering af kromosomaberrationer
DK3254093T3 (da) Fremgangsmåde og anordning til bestemmelse af vandindhold
DK3128910T3 (da) Fremgangsmåde til bestemmelse af tværsnitsarealet og voluminet af et objekt
EP3343231A4 (en) AUTOMATED ANALYZER
DK3422936T3 (da) Apparat til prøveudtagning af en eller flere analytter
EP3373005A4 (en) REAGENT AND METHOD FOR TESTING FOR CARDIAL TROPONIN-I
FI20136151A7 (fi) Menetelmä saostumanestoaineen määrittämiseksi näytteestä
EP3370064A4 (en) REAGENT AND METHOD FOR MEASURING A THROMBIN ANTITHROMBIN COMPLEX
DK3394615T3 (da) Fremgangsmåde til påvisning af tilstedeværelse eller fravær af et koagel i en væskeprøveanalysator
DK3365791T3 (da) Teknikker til bestemmelse af virkningerne på klientsiden af adfærd på serversiden ved hjælp af kontrolværdianalyse
EP3312614C0 (en) SAMPLE ANALYZER
EP3303605C0 (en) MULTI-MEDIATOR REAGENT FORMULATIONS FOR USE IN ELECTROCHEMICAL DETECTION
EP3561511A4 (en) BLOOD LIPID MEASURING TAPE
DK3384045T3 (da) Fremgangsmåde til bestemmelse af celleklonalitet